Research at MD Anderson
Scroll Ahead
Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
August 2021 CPRIT Funding
6.75M
for faculty recruitments and high-impact, high-risk awards
3M
to build clinical trial network infrastructure across Texas
3M
for early clinical investigator awards
In August, the Cancer Prevention and Research Institute of Texas
(CPRIT) announced its 2021 funding. MD Anderson was awarded a total
of $12.75 million to support basic, clinical, translational and
prevention research effort. See how it breaks down.
NIH Funding
MD Anderson's research and training are aided by more than $168 million in NIH grant funding, which helps power our mission to end cancer.
View our NIH award summaryDepartments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Research Areas
Since 1941, MD Anderson has been home to some of the brightest minds across a variety of cancer research areas.
Resources
MD Anderson provides research tools and resources to fuel the discoveries of our scientists.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program® was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.
Learn more about the Moon Shots ProgramResearch Highlights
FLT3-positive AML
Pre-cancer Atlas
Statins for TNBC
Peritoneal cancer study
SABR study
Cancer exosomes
Melanoma treatment
FISH testing
Building trust through health disparities research
Lorna H. McNeill, Ph.D., got her first hands-on experience in the field of public health while organizing a blood drive. This event sparked a passion for understanding and implementing new ways to make health care more accessible to all communities. Now, as professor and chair of MD Anderson’s department of Health Disparities Research, McNeill is sharing her story and advice for the next generation of health disparity researchers.
What is Patient Mosaic™?
Program uses whole genome sequencing and genetic analysis to personalize cancer treatment